Walgreens Boots Alliance Revenues And Revenue Growth From 2012 To 2016

This report provides the last five years revenues and revenue growth of Walgreens Boots Alliance, Inc. (WBA) from 2012 to 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. Walgreens Boots Alliance reported a revenue growth of 13.4% year-over-year during 2016. The revenues and the revenue growth correspond to the fiscal year ending in August.

Walgreens Boots Alliance Revenues From 2012 To 2016

Here are the revenues and the revenue growth details of Walgreens Boots Alliance during the last five years:

  • Walgreens Boots Alliance generated a total of $71.6 billion revenues during 2012. Walgreens Boots Alliance reported a revenue growth of -0.8% year-over-year during 2012.
  • Walgreens Boots Alliance generated a total of $72.2 billion revenues during 2013. Walgreens Boots Alliance reported a revenue growth of 0.8% year-over-year during 2013.
  • Walgreens Boots Alliance generated a total of $76.4 billion revenues during 2014. Walgreens Boots Alliance reported a revenue growth of 5.8% year-over-year during 2014.
  • Walgreens Boots Alliance generated a total of $103.4 billion revenues during 2015. Walgreens Boots Alliance reported a revenue growth of 35.4% year-over-year during 2015.
  • Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. Walgreens Boots Alliance reported a revenue growth of 13.4% year-over-year during 2016.

Why Analyze Revenue Growth?

Revenue growth is the most commonly analyzed financial metric. Revenue Growth is the percent increase (or decrease) of a company's revenue between two time periods. It is computed by using the following formula: ((revenues during the time period two - revenues during the time period one) / revenues during the time period one)*100. If the time periods are two consecutive years, then the revenue growth is referred to as the annual revenue growth year-over-year. If the time periods are two consecutive quarters, then the revenue growth is referred to as the quarterly revenue growth quarter-over-quarter. If the time periods refer to the same quarter in the two consecutive years, then the revenue growth is referred to as quarterly revenue growth year-over-year. In case the time periods are two non-consecutive years, then the revenue CAGR (Commutative Annual Growth Rate) is computed.

Revenue growth analysis is important for a number of reasons. First, it helps in understanding how a business is performing. If the revenue growth rates are positive, it means the business is performing well and the revenues are increasing. If the revenue growth rates are negative, it means the revenues are declining and the company needs to take measures to increase them. If they don't, the company will continue to shrink. Second, a company's historical revenue growth analysis along with the market size and market share analysis helps in forecasting the future revenues of a company. Third, a comparison of a company's growth rates with its competitors helps in determining who is winning more business. A revenue growth higher than the industry average translates into increasing market share. Companies with very high revenue growth rates have the potential to be the industry disrupters.

Walgreens Boots Alliance Ranking

With $117.4 billion revenues, Walgreens Boots Alliance ranked number 17 in the R&P Research list of top-3000 public companies in the US by revenues during 2016. Each one of the top-3000 companies generated more than $50 million of annual revenues during 2016.

The top-20 companies in the US by revenues during 2016 were:

  1. Walmart ($482.1 billion)
  2. ExxonMobil ($226.1 billion)
  3. Berkshire Hathaway ($223.6 billion)
  4. Apple ($215.6 billion)
  5. McKesson ($190.9 billion)
  6. UnitedHealth Group ($184.8 billion)
  7. CVS Health ($177.5 billion)
  8. General Motors ($166.4 billion)
  9. AT&T ($163.8 billion)
  10. Ford Motor ($151.8 billion)
  11. AmerisourceBergen ($146.8 billion)
  12. Amazon ($136 billion)
  13. Verizon ($126 billion)
  14. General Electric ($123.7 billion)
  15. Cardinal Health ($121.5 billion)
  16. Costco ($118.7 billion)
  17. Walgreens Boots Alliance ($117.4 billion)
  18. Chevron ($114.5 billion)
  19. Kroger ($109.8 billion)
  20. Express Scripts Holding ($100.3 billion)

For the purpose of performance benchmarking of a company with a sector or industry average, R&P Research associates every company with one sector and one industry. An industry consists of companies with related/similar business models. A sector comprises of a group of related/similar industries. For high-level analysis purposes, related/similar sectors are grouped into sector groups.

For example, Healthcare sector group is comprised of Life Sciences sector and Healthcare Services sector. Life Sciences sector is comprised of following industries: Pharmaceuticals; Medical Devices; Biotechnology; Diagnostics & Scientific Instruments. Healthcare Services sector is comprised of following industries: Drug Stores, PBM and Distributors; Healthcare Payers; Healthcare Providers; Medical Software; Healthcare Research Services.

Walgreens Boots Alliance is associated with Healthcare Sector Group, Healthcare Services Sector, and Drug Stores, PBM and Distributors Industry.

With $117.4 billion revenues, Walgreens Boots Alliance ranked number 6 of all the companies in the US Healthcare sector group. There were a total of 290 public companies in the US Healthcare sector group that had revenues greater than $50 million during 2016.

The top-10 companies in the US Healthcare sector group by revenues during 2016 were:

  1. McKesson ($190.9 billion)
  2. UnitedHealth Group ($184.8 billion)
  3. CVS Health ($177.5 billion)
  4. AmerisourceBergen ($146.8 billion)
  5. Cardinal Health ($121.5 billion)
  6. Walgreens Boots Alliance ($117.4 billion)
  7. Express Scripts Holding ($100.3 billion)
  8. Anthem ($84.9 billion)
  9. J&J ($71.9 billion)
  10. Aetna ($63.2 billion)

Healthcare sector group is comprised of the following sectors: Life Sciences; Healthcare Services.

With $117.4 billion revenues, Walgreens Boots Alliance ranked number 6 of all the companies in the US Healthcare Services sector. There were a total of 93 public companies in the US Healthcare Services sector that had revenues greater than $50 million during 2016.

The top-10 companies in the US Healthcare Services sector by revenues during 2016 were:

  1. McKesson ($190.9 billion)
  2. UnitedHealth Group ($184.8 billion)
  3. CVS Health ($177.5 billion)
  4. AmerisourceBergen ($146.8 billion)
  5. Cardinal Health ($121.5 billion)
  6. Walgreens Boots Alliance ($117.4 billion)
  7. Express Scripts Holding ($100.3 billion)
  8. Anthem ($84.9 billion)
  9. Aetna ($63.2 billion)
  10. Humana ($54.4 billion)

Healthcare Services sector is comprised of the following industries: Drug Stores, PBM and Distributors; Healthcare Payers; Healthcare Providers; Medical Software; Healthcare Research Services. The definitions for each of the industries is as follows:

  • Drug Stores, PBM and Distributors industry includes nationwide drugstore chains, pharmacy benefit management (PBM) companies, and drug distributors. Drug stores also offer walk-in clinics and related pharmacy services. Distributors distribute branded and generic pharmaceutical and other healthcare products to hospitals, pharmacies and other healthcare providers. PBMs are primarily responsible for developing and maintaining the formulary, contracting with pharmacies, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims.
  • Healthcare Payers industry includes healthcare insurance companies that finance or reimburse the cost of health services. These companies also offer collaborative care, population health management, healthcare technology, Pharmacy Benefit Management, analytics, consulting and administrative services.
  • Healthcare Providers industry consist primarily of hospitals but recent changes in the health services industry have contributed to both increasing numbers of other types of facility providers. Companies in this industry include traditional healthcare providers and emerging healthcare facility providers like ambulatory surgery centers, behavioral healthcare facilities, dialysis clinics, home health care companies and others.
  • Medical Software industry includes companies that offer any software item or system used within a healthcare context. These companies offer standalone software used for diagnostic, therapeutic purposes, clinical financial and operational purposes.
  • Healthcare Research Services industry includes companies that offer biopharmaceutical development services, commercial outsourcing services; commercial pharmaceutical sales and service organizations, consulting, health information analytics and technology consulting.

With $117.4 billion revenues, Walgreens Boots Alliance ranked number 5 of all the companies in the US Drug Stores, PBM and Distributors industry. There were a total of 14 public companies in the US Drug Stores, PBM and Distributors industry that had revenues greater than $50 million during 2016.

The top-10 companies in the US Drug Stores, PBM and Distributors industry by revenues during 2016 were:

  1. McKesson ($190.9 billion)
  2. CVS Health ($177.5 billion)
  3. AmerisourceBergen ($146.8 billion)
  4. Cardinal Health ($121.5 billion)
  5. Walgreens Boots Alliance ($117.4 billion)
  6. Express Scripts Holding ($100.3 billion)
  7. Rite Aid ($30.7 billion)
  8. Henry Schein ($11.6 billion)
  9. Owens & Minor ($9.7 billion)
  10. Patterson Companies ($5.4 billion)

Companies Segmentation

To identify and analyze high/low growth or most/least profitable similar-size companies in different sectors or industries, R&P research classifies all companies into different segments based upon their revenues, revenue growth, and net profit margins.

Based upon their annual revenues, the companies are classified into one of the following four segments:

  1. Mega companies, having revenues greater than $50 billion.
  2. Very Large companies, having revenues between $10 billion and $50 billion.
  3. Large companies, having revenues between $1 billion and $10 billion.
  4. Mid-size companies, having revenues between $50 million and $1 billion.

With $117.4 billion revenues, Walgreens Boots Alliance was in the Mega companies revenue segment during 2016. There were a total of 54 companies in the Mega companies revenue segment during 2016.

Based upon their annual revenue growth, the companies are classified into one of the following eight segments:

  1. Very High positive growth companies, having annual revenue growth greater than 50%.
  2. High positive growth companies, having annual revenue growth between 20% and 50%.
  3. Medium positive growth companies, having annual revenue growth between 5% and 20%.
  4. Low positive growth companies, having annual revenue growth between 0% and 5%.
  5. Low negative growth companies, having annual revenue growth between -5% and 0%.
  6. Medium negative growth companies, having annual revenue growth between -20% and -5%.
  7. High negative growth companies, having annual revenue growth between -50% and -20%.
  8. Very High negative growth companies, having annual revenue growth less than -50%.

With 13.4% revenue growth year-over-year, Walgreens Boots Alliance was in the Medium positive revenue growth segment during 2016. There were a total of 876 companies in the Medium positive revenue growth segment during 2016. Of the US top-3000 companies, 1985 (nearly two-third of the total) had positive revenue growth and 1015 (nearly one-third of the total) had negative revenue growth during 2016.

Based upon their annual net profit margin, the companies are classified into one of the following eight segments:

  1. Very High positive margin companies, having net profit margin greater than 50%.
  2. High positive margin companies, having net profit margin between 20% and 50%.
  3. Medium positive margin companies, having net profit margin between 5% and 20%.
  4. Low positive margin companies, having net profit margin between 0% and 5%.
  5. Low negative margin companies, having net profit margin between -5% and 0%.
  6. Medium negative margin companies, having net profit margin between -20% and -5%.
  7. High negative margin companies, having net profit margin between -50% and -20%.
  8. Very High negative margin companies, having net profit margin less than -50%.

With a net margin of 3.6%, Walgreens Boots Alliance was in the Low positive net profit margin segment during 2016. There were a total of 707 companies in the Low positive net profit margin segment during 2016. Of the US top-3000 companies, 2244 (nearly three-fourth of the total) had positive net profit margin and 756 (nearly one-fourth of the total) had negative net profit margin during 2016.

Company Business Summary

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services; and manages in-store clinics. As of August 31, 2016, this segment operated 8,175 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, toiletry, and other consumer products through its pharmacy-led health and beauty stores, as well as through boots.com. It is also involved in optical practice and related contract manufacturing operations. This segment operated 4,673 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 636 optical practices. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in France, the United Kingdom, Germany, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Data Source

The chart and the data on this page are sourced from the R&P Research Industry Intelligence Platform. The platform provides the key financial metrics for all the public companies in the United States. The platform empowers users to compare last five or 15 years financial data of a company with the other companies or the industry averages. This benchmarking exercise yields powerful insights that can drive better business decisions.


Industry Peers and Competitors of Walgreens Boots Alliance

CVS Health (CVS) Business Analysis – Analyze Historical Performance, Strategic Priorities,...

CVS Health Corp with $178 billion revenues in the year 2016 was the number 2 Drug Stores, PBM and Distributors company. Read this report to know the top competitors of CVS Health and identify growth and cost optimization opportunities of CVS Health

AmerisourceBergen (ABC) Business Analysis – Analyze Historical Performance, Strategic Priorities, And...

AmerisourceBergen Corp with $147 billion revenues in the year 2016 was the number 3 Drug Stores, PBM and Distributors company. Read this report to know the top competitors of AmerisourceBergen and identify growth and cost optimization opportunities of AmerisourceBergen

Cardinal Health (CAH) Business Analysis – Analyze Historical Performance, Strategic Priorities,...

Cardinal Health Inc with $122 billion revenues in the year 2016 was the number 4 Drug Stores, PBM and Distributors company. Read this report to know the top competitors of Cardinal Health and identify growth and cost optimization opportunities of Cardinal Health

Express Scripts Holding (ESRX) Business Analysis – Analyze Historical Performance, Strategic...

Express Scripts Holding Co. with $100 billion revenues in the year 2016 was the number 6 Drug Stores, PBM and Distributors company. Read this report to know the top competitors of Express Scripts Holding and identify growth and cost optimization opportunities of Express Scripts Holding

Rite Aid (RAD) Business Analysis – Analyze Historical Performance, Strategic Priorities,...

Rite Aid Corp with $31 billion revenues in the year 2016 was the number 7 Drug Stores, PBM and Distributors company. Read this report to know the top competitors of Rite Aid and identify growth and cost optimization opportunities of Rite Aid

Henry Schein (HSIC) Business Analysis – Analyze Historical Performance, Strategic Priorities,...

Henry Schein Inc with $12 billion revenues in the year 2016 was the number 8 Drug Stores, PBM and Distributors company. Read this report to know the top competitors of Henry Schein and identify growth and cost optimization opportunities of Henry Schein

Revenues Analysis

Walgreens Boots Alliance (WBA) Revenues And Revenue Growth From 2012 To...

This report provides the last five years revenues and revenue growth of Walgreens Boots Alliance, Inc. (WBA) from 2012 to 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. Walgreens Boots Alliance reported a revenue growth of 13.4% year-over-year during 2016. The revenues and the revenue growth correspond to the fiscal year ending in August.

Walgreens Boots Alliance (WBA) Revenues And Revenue Growth From 2002 To...

This report provides the last fifteen years revenues and revenue growth of Walgreens Boots Alliance, Inc. (WBA) from 2002 to 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. Walgreens Boots Alliance reported a revenue growth of 13.4% year-over-year during 2016. The revenues and the revenue growth correspond to the fiscal year ending in August.

Walgreens Boots Alliance (WBA) Revenue Growth Comparison With Industry Growth From...

This report provides a comparison of Walgreens Boots Alliance, Inc. (WBA) revenue growth with Drug Stores, PBM and Distributors industry growth during the last five years from 2012 to 2016. Walgreens Boots Alliance reported a revenue growth of 13.4% year-over-year during 2016. The Drug Stores, PBM and Distributors industry growth was 10.3% year-over-year during 2016. Walgreens Boots Alliance growth was faster than the industry during 2016.

Profit Analysis

Walgreens Boots Alliance (WBA) Net Profit And Net Margin From 2012...

This report provides the last five years net profit and net margin of Walgreens Boots Alliance, Inc. (WBA) from 2012 to 2016. Walgreens Boots Alliance reported a total net income of $4.2 billion during 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. Walgreens Boots Alliance net profit margin was 3.6% during 2016. The net profit and the net profit margin correspond to the fiscal year ending in August.

Walgreens Boots Alliance (WBA) Net Profit And Net Margin From 2002...

This report provides the last fifteen years net profit and net margin of Walgreens Boots Alliance, Inc. (WBA) from 2002 to 2016. Walgreens Boots Alliance reported a total net income of $4.2 billion during 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. Walgreens Boots Alliance net profit margin was 3.6% during 2016. The net profit and the net profit margin correspond to the fiscal year ending in August.

Walgreens Boots Alliance (WBA) Net Profit Margin Comparison With Industry From...

This report provides a comparison of Walgreens Boots Alliance, Inc. (WBA) net profit margin with Drug Stores, PBM and Distributors industry net profit margin during the last five years from 2012 to 2016. Walgreens Boots Alliance reported a net profit margin of 3.6% during 2016. The Drug Stores, PBM and Distributors industry net profit margin was 2.1% during 2016. Walgreens Boots Alliance was more profitable than the industry during 2016.

Cost & Expenses Analysis

Walgreens Boots Alliance (WBA) Cost of Sales (COGS) Analysis From 2012...

This report provides the last five years cost of sales (COGS) analysis of Walgreens Boots Alliance, Inc. (WBA) from 2012 to 2016. Walgreens Boots Alliance spent a total of $87.5 billion on COGS during 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. As a percentage of revenues, Walgreens Boots Alliance spent 74.5% of its total revenues on COGS during 2016. The cost of sales (COGS) numbers are for the fiscal year ending in August.

Walgreens Boots Alliance (WBA) Research & Development (R&D) Spending Analysis 2016

R&D spending analysis for Walgreens Boots Alliance is not available because either the company does not provide the data or we don't have it.

Walgreens Boots Alliance (WBA) Sales, Marketing, General & Administrative (SG&A) Spending...

This report provides the last five years sales, marketing, general & administrative (SG&A) expenses of Walgreens Boots Alliance, Inc. (WBA) from 2012 to 2016. Walgreens Boots Alliance spent a total of $23.9 billion on sales, marketing, general, and administrative (SG&A) activities during 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. As a percentage of revenues, Walgreens Boots Alliance spent 20.4% of its total revenues on SG&A activities during 2016. The SG&A spending numbers are for the fiscal year ending in August.

Working Capital Analysis

Walgreens Boots Alliance (WBA) Inventory Spending Analysis From 2012 To 2016

This report provides the last five years inventory spending analysis of Walgreens Boots Alliance, Inc. (WBA) from 2012 to 2016. Walgreens Boots Alliance invested a total of $9 billion on inventories during 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. As a percentage of revenues, Walgreens Boots Alliance invested 7.6% of its total revenues on inventories during 2016. The inventory numbers are for the fiscal year ending in August.

Walgreens Boots Alliance (WBA) Accounts Receivable (A/R) Analysis From 2012 To...

This report provides the last five years Accounts Receivable (A/R) analysis of Walgreens Boots Alliance, Inc. (WBA) from 2012 to 2016. Walgreens Boots Alliance invested a total of $6.3 billion on accounts receivable during 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. As a percentage of revenues, Walgreens Boots Alliance invested 5.3% of its total revenues on accounts receivable during 2016. The accounts receivable numbers are for the fiscal year ending in August.

Walgreens Boots Alliance (WBA) Accounts Payable (A/P) Analysis From 2012 To...

This report provides the last five years Accounts Payable (A/P) analysis of Walgreens Boots Alliance, Inc. (WBA) from 2012 to 2016. Walgreens Boots Alliance invested a total of $11 billion on accounts payable during 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. As a percentage of revenues, Walgreens Boots Alliance invested 9.4% of its total revenues on accounts payable activities during 2016. The accounts payable numbers are for the fiscal year ending in August.

Asset Management Analysis

Walgreens Boots Alliance (WBA) Property, Plant & Equipment (PP&E) Investment Analysis...

This report provides the last five years property, plant & equipment (PP&E) investment analysis of Walgreens Boots Alliance, Inc. (WBA) from 2012 to 2016. Walgreens Boots Alliance invested a total of $14.3 billion on property, plant & equipment (PP&E) activities during 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. As a percentage of revenues, Walgreens Boots Alliance invested 12.2% of its total revenues on PP&E activities during 2016. The PP&E investment numbers are for the fiscal year ending in August.

Walgreens Boots Alliance (WBA) Intangible Assets Analysis From 2012 To 2016

This report provides the last five years Intangible assets analysis of Walgreens Boots Alliance, Inc. (WBA) from 2012 to 2016. Walgreens Boots Alliance invested a total of $25.8 billion on Intangible assets during 2016. Walgreens Boots Alliance generated a total of $117.4 billion revenues during 2016. As a percentage of revenues, Walgreens Boots Alliance invested 22% of its total revenues on intangible assets during 2016. The Intangible asset numbers are for the fiscal year ending in August.

Got Questions?

Get in touch with us. We are happy to help!

Contact Us:


sales@revenuesandprofits.com